Travoprost 0.004% Eye Drop Franchise for Glaucoma Management in Mumbai Maharashtra

Travopine Eye Drop for Reducing Intraocular Pressure in Delhi NCR

Travoprost Ophthalmic Solution for Chronic Glaucoma in Chennai Tamil Nadu

Exclusive Travopine Eye Drop PCD Franchise in Kolkata West Bengal

High-Demand Travoprost Eye Drop Solution in Bangalore Karnataka
Travopine Eye Drop 0.004% w/v for Effective Glaucoma Care in Hyderabad Telangana

Home/Products /travoporst-ip-0-004-w-v-benzalkonium-chloride-solution-ip-0-02-v-v-eye-drop

About the Product

Description


Travopine Eye Drop (Travoprost 0.004% w/v) is a prostaglandin analogue ophthalmic solution designed for the management of glaucoma and ocular hypertension. Travoprost effectively reduces intraocular pressure, preventing optic nerve damage and vision loss in patients with chronic glaucoma.

Essential for long-term glaucoma care, this eye drop is highly demanded by hospitals, clinics, and ophthalmic specialists. Travopine Eye Drop offers an exclusive PCD franchise opportunity, making it ideal for B2B pharma distribution, manufacturing, export, and competitive pricing, allowing your business to capitalize on a growing specialty ophthalmic market.

Mild side effects may include temporary stinging, burning, or slight redness immediately after application. Rarely, patients may experience allergic reactions or excessive irritation. Consult an ophthalmologist if such symptoms persist or worsen.

Travopine Eye Drop is indicated for dry eyes, minor irritations, and as a prophylactic antiseptic in conditions prone to bacterial contamination. It is also used before and after ocular procedures to reduce the risk of infection, ensuring the eyes remain hydrated, clean, and protected.

Use Povidyle Eye Drop exactly as directed, typically 1–2 drops in the affected eye(s) 2–3 times daily or as prescribed. Avoid contact between the dropper tip and the eye to prevent contamination. Do not use if the solution becomes cloudy or changes color.

Store Travopine Eye Drop in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children and ensure it is used within the expiry date mentioned on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Travoprost IP 0.004% w/v + Benzalkonium Chloride Solution IP 0.02% v/v Eye Drops in the PCD pharma franchise market?

Travoprost IP 0.004% w/v + Benzalkonium Chloride Solution IP 0.02% v/v Eye Drops have strong demand in the ophthalmology, glaucoma management, and specialty eye care segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ophthalmic and specialty healthcare portfolios.

Why should medical distributors include Travoprost IP 0.004% w/v + Benzalkonium Chloride Solution IP 0.02% v/v Eye Drops in their product range?

Medical distributors and agencies can benefit from consistent demand for glaucoma and ocular hypertension management under specialist medical supervision. Travoprost IP 0.004% w/v is a prostaglandin analogue that helps lower intraocular pressure by increasing the outflow of aqueous humor Commonly prescribed for the management of open-angle glaucoma and ocular hypertension, as advised by ophthalmologists Helps reduce elevated intraocular pressure, thereby supporting the prevention of progressive optic nerve damage associated with glaucoma Benzalkonium Chloride Solution IP 0.02% v/v acts as a preservative to maintain the sterility and stability of the ophthalmic formulation Sterile eye drop formulation provides convenient once-daily administration and promotes adherence to long-term therapy Requires regular ophthalmic monitoring of intraocular pressure and overall treatment response during therapy Frequently utilized in ophthalmology clinics, glaucoma care centers, eye hospitals, and specialty eye care facilities Widely prescribed by ophthalmologists and glaucoma specialists This strengthens a comprehensive ophthalmology and glaucoma care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Travoprost IP 0.004% w/v + Benzalkonium Chloride Solution IP 0.02% v/v Eye Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent prescription demand, long-term patient usage, specialty ophthalmology market opportunities, reliable supply chain support, repeat purchases, and attractive margins in the glaucoma care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality ophthalmic products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.